RNA in Cancer Diagnostics: From Basic to Translational Application

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 205

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, Chongqing University, Chongqing 400030, China
Interests: cancer diagnostics

Special Issue Information

Dear Colleagues,

This Special Issue focuses on publishing original research and review articles focusing on, but not limited to the following:

  1. Novel writer, reader, and eraser enzymes and proteins of RNA modifications;
  2. Detection and characterization of modified nucleotides in human cancers;
  3. Role of RNA post-transcriptional regulome (RNA-binding proteins, RNA modifiers, and modulatory RNAs) in cancer, and their molecular interplay with microRNAs and other oncogenic RNAs;
  4. Molecular interplay between RNA and RNA modification regulators in cancers;
  5. Diagnostic application of RNA modification-related signatures, development of RNA modification-based scoring system, and its translational application in cancer;
  6. Novel RNA modification molecular mechanisms that may contribute to remodeling the tumor microenvironment;
  7. Novel mechanisms or strategies to exploit RNA modification-based therapy.

Prof. Dr. Chengxiong Xu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular oncology
  • RNA modification
  • cancer progression
  • prognosis
  • personalized treatment

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop